NCT00642850View on ClinicalTrials.gov

STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

188

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Anemia

Interventions

DRUG

methoxy polyethylene glycol-epoetin beta [Mircera]

120, 200 or 360 micrograms iv monthly (starting dose)

Trial Locations (24)

14000

Prague

38127

Český Krumlov

38629

Strakonice

76275

Znojmo

656 91

Brno

405 99

Děčín

736 24

Havířov

500 05

Hradec Králové

586 33

Jihlava

360 73

Karlovy Vary

280 20

Kolin III

460 63

Liberec

741 11

Nový Jičín

775 20

Olomouc

708 52

Ostrava

397 23

Písek

128 08

Prague

150 30

Prague

169 00

Prague

787 01

Šumperk

390 03

Tábor

415 01

Teplice

674 01

Třebíč

401 13

Ústí nad Labem

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT00642850 - STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients | Biotech Hunter | Biotech Hunter